跳至主要内容
临床试验/ACTRN12613000451707
ACTRN12613000451707已完成1 期

A cross-over, double-blind, randomised controlled, proof of concept trial of berryfruit extract versus placebo on the FeNO level of 28 steroid naive subjects with diagnosed asthma and an FeNO of >40ppb.

The New Zealand Institute for Plant & Food Research Ltd0 个研究点目标入组 28 人开始时间: 2013年4月19日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Doctor diagnosis of asthma
  • Steroid naive (no inhaled or oral corticosteroid in the last 90 days)
  • Exhaled FeNO of >40ppb
  • Aged 18-75

排除标准

  • Unable to provide informed consent
  • Unable or unwilling to comply with study procedures, including not consuming confounding foodstuffs during study periods
  • Known hypersensitivity to berryfruit polyphenolic compounds Known pregnancy
  • Any other safety concern at the investigator’s discretion

研究者

发起方
The New Zealand Institute for Plant & Food Research Ltd

相似试验

进行中(未招募)
不适用
A controlled, randomized, double-blind, cross-over study of the onset of analgesic effect of two formulations of ibuprofen for the treatment of pain after oral surgery.PainMedDRA version: 12.0Level: LLTClassification code 10033371Term: Pain
EUCTR2009-015589-74-SEycomed Sweden Holding 2 AB140
进行中(未招募)
不适用
A controlled, randomized, double-blind, cross-over study of the onset of analgesic effect of two formulations of ibuprofen for the treatment of pain after oral surgery.PainMedDRA version: 12.0Level: LLTClassification code 10033371Term: Pain
EUCTR2009-015589-74-DKycomed Sweden Holding 2 AB140
进行中(未招募)
2 期
To check how GlucoSEB affects the blood sugar level of diabetic and prediabetic patients after eating a meal.
CTRI/2023/10/058380Advanced Enzymes Technologies Ltd.
进行中(未招募)
不适用
Effect of SBO-635 on mouth healthHalitosisOral Health
ISRCTN10220812Innovation Labo Research42
进行中(未招募)
不适用
Crossover clinical trial, randomized, double blind, placebo controlled trial. Modulation of cellular mediators and repair endothelial damage in patients with chronic renal disease through inhibition of xanthine oxidase.Patients with chronic kidney disease and asymptomatic hyperuricemia on the balance of mechanisms of vascular injury and repair.MedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2013-001640-56-ESFundación Para la Investigación Biomédica de Córdoba
The effect of berryfruit extract on airways... | 临床试验